Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229

Watchlist Manager
Zhejiang Ausun Pharmaceutical Co Ltd Logo
Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
Watchlist
Price: 8.65 CNY -1.59% Market Closed
Market Cap: 7.2B CNY
Have any thoughts about
Zhejiang Ausun Pharmaceutical Co Ltd?
Write Note

Zhejiang Ausun Pharmaceutical Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Ausun Pharmaceutical Co Ltd
Total Equity Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
Total Equity
ÂĄ2.3B
CAGR 3-Years
24%
CAGR 5-Years
30%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Equity
ÂĄ25.8B
CAGR 3-Years
13%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Equity
ÂĄ13.7B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Equity
ÂĄ42.6B
CAGR 3-Years
9%
CAGR 5-Years
14%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Equity
ÂĄ39.4B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Equity
ÂĄ151.9m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Ausun Pharmaceutical Co Ltd's Total Equity?
Total Equity
2.3B CNY

Based on the financial report for Jun 30, 2024, Zhejiang Ausun Pharmaceutical Co Ltd's Total Equity amounts to 2.3B CNY.

What is Zhejiang Ausun Pharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
30%

Over the last year, the Total Equity growth was 11%. The average annual Total Equity growth rates for Zhejiang Ausun Pharmaceutical Co Ltd have been 24% over the past three years , 30% over the past five years .

Back to Top